SUPN
Supernus Pharmaceuticals Inc
42.10$
-2.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.8% | -7.7% | +31.7% | +6.0% | +10.0% | +2.3% | +10.1% | +3.5% | +12.6% | -26.3% | +22.5% | -2.4% | -1.7% | -5.4% | +33.4% | +22.4% | -7.5% | -8.8% | +7.9% | +5.0% | +7.1% | -4.1% | +11.5% | +4.3% | -5.7% | -8.1% | -11.8% | +13.5% | +6.8% | -12.6% | +17.2% | +4.4% | -0.9% | -14.0% | +10.4% | +16.1% | +10.1% | -1.8% | +5.5% | – | |
| – | +10.0% | -21.8% | +30.9% | +10.1% | -2.3% | -21.1% | +12.4% | +14.2% | -0.5% | -12.0% | +9.8% | +19.2% | -14.7% | +0.9% | +102.0% | +155.0% | -13.3% | -19.3% | +67.4% | -27.7% | -6.0% | +5.5% | +14.1% | +26.5% | -11.3% | +2.2% | -10.1% | -7.1% | +0.1% | -16.9% | +9.9% | -1.9% | +48.4% | -39.6% | +6.7% | +12.7% | +21.3% | +1.7% | +43.9% | – | |
| – | +9.8% | -6.8% | +31.7% | +5.8% | +10.7% | +3.4% | +10.0% | +3.1% | +13.1% | -26.8% | +23.1% | -3.3% | -1.0% | -5.7% | +30.3% | +13.0% | -6.5% | -7.2% | +0.3% | +12.1% | +9.0% | -5.3% | +11.2% | +1.3% | -4.7% | -9.7% | -12.2% | +17.3% | +7.8% | -12.0% | +18.1% | +5.1% | -6.4% | -9.5% | +10.9% | +16.5% | +8.9% | -2.3% | +0.6% | – | |
| – | +68.4% | -27.6% | +12.7% | +19.9% | +24.6% | +16.9% | +6.0% | +1.9% | +46.1% | -48.4% | +10.2% | -0.2% | +16.8% | -4.3% | +17.5% | -24.3% | +6.5% | +91.1% | -54.9% | +27.2% | +7.2% | -1.1% | -21.4% | +19.3% | -9.1% | +19.3% | +14.9% | -7.1% | +3.1% | +6.8% | +5.0% | +10.9% | -1.3% | -6.0% | -17.9% | +32.8% | -5.2% | +41.7% | -25.3% | – | |
| – | -9.0% | -7.8% | +17.4% | +23.5% | -16.5% | +11.1% | +0.2% | +1.0% | -0.1% | -65.1% | -6.5% | +2.1% | +181.0% | -54.2% | +55.1% | -16.2% | +20.7% | +16.7% | -8.1% | +0.8% | +377.0% | -70.6% | -10.2% | -1.1% | -2.4% | +9.2% | -5.2% | -3.6% | +0.3% | +3.6% | +0.6% | -43.1% | +60.9% | +7.5% | +6.6% | +261.1% | -61.8% | +219.3% | -67.4% | – | |
| – | +26.1% | -10.6% | +21.3% | +17.2% | -7.2% | +11.7% | +7.9% | +2.0% | +17.3% | -21.6% | +3.0% | -0.8% | -3.6% | +11.3% | +17.8% | +6.6% | +5.7% | +25.3% | -20.0% | +19.0% | +55.3% | -12.7% | +4.3% | +10.7% | -28.1% | +13.7% | +5.5% | -4.5% | +15.5% | -10.4% | -2.0% | -8.3% | +8.0% | +13.9% | -5.4% | +71.0% | -25.1% | +10.2% | +26.3% | – | |
| – | -17.9% | +3.0% | +55.3% | -14.3% | +53.7% | -8.6% | +13.8% | +4.9% | +6.4% | -36.2% | +67.5% | -6.7% | +2.7% | -28.9% | +57.0% | +23.3% | -23.4% | -69.3% | +158.2% | -4.4% | -77.9% | -72.7% | +476.8% | -113.4% | – | -84.9% | -439.8% | – | -112.2% | – | – | +81.0% | -47.6% | -147.9% | – | -596.1% | – | -153.8% | – | – | |
| – | -21.1% | +10.3% | -79.2% | -28.9% | +3.2% | +786.3% | +289.8% | +0.7% | +0.6% | +4.8% | -8.2% | +5.1% | +3.7% | -2.0% | +1.0% | +4.7% | +0.1% | +0.0% | -10.3% | +8.4% | +0.2% | -67.3% | -6.8% | -4.8% | -7.5% | -5.6% | -39.5% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -18.7% | +4.3% | +62.9% | -13.3% | +53.0% | -11.1% | +8.6% | +7.4% | +6.6% | -37.5% | +76.4% | -7.4% | +3.3% | -29.0% | +62.6% | +11.7% | -24.7% | -72.5% | +185.8% | -7.3% | -92.9% | +617.8% | -23.1% | -103.9% | – | -74.3% | -289.9% | – | -90.0% | -75.5% | +10,723.9% | +70.9% | -41.3% | -122.1% | – | -447.7% | – | – | – | – | |
| – | – | +381.0% | +52.8% | -23.3% | +208.0% | -77.4% | -35.4% | +168.0% | +54.0% | -54.2% | +69.8% | +7.1% | -27.5% | -3.4% | +66.9% | +1.4% | -29.8% | -41.3% | +43.4% | -1.5% | -105.3% | – | – | -163.4% | – | -182.1% | – | – | -100.7% | – | +5,266.4% | +0.9% | +71.5% | -45.8% | -197.2% | – | – | -266.9% | – | – | |
| – | -76.8% | -28.1% | +68.7% | -8.1% | -14.4% | +92.9% | +16.6% | -8.9% | -7.6% | -29.2% | +78.4% | -11.8% | +14.8% | -35.0% | +61.1% | +15.4% | -23.1% | -81.5% | +316.7% | -9.1% | -88.7% | +949.0% | -69.3% | -77.8% | +1,356.9% | -33.5% | -104.9% | – | – | -89.4% | +15,961.3% | +93.3% | -60.2% | -177.2% | – | -300.5% | – | – | – | – | |
| – | -17.0% | +3.3% | +56.4% | -2.5% | +34.8% | -8.1% | +13.3% | +5.0% | +41.1% | -42.8% | +56.4% | -16.7% | +16.9% | -24.6% | +53.5% | +18.9% | -23.0% | -54.0% | +83.4% | -4.1% | -50.2% | +83.8% | -8.8% | -33.5% | +149.8% | -46.0% | -85.5% | +604.2% | -28.6% | -27.2% | +135.9% | +67.1% | -30.5% | -60.7% | +113.8% | -187.2% | – | -24.3% | -246.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.